Author name: DrugChatter

Patients are asking ChatGPT about your drug. Physicians are consulting Gemini before prescribing. Regulators are building their own AI review […]

The Invisible Conversation Shaping Your Drug’s Reputation Somewhere right now, a patient is asking an AI chatbot whether their statin

How ChatGPT, Gemini, and a dozen other AI chatbots became the most unmonitored channel in pharmaceutical brand strategy — and

The medical information landscape has shifted from static search results to dynamic, generative responses. While pharmaceutical companies have spent decades

Audit ChatGPT for FDA Compliance Pharmaceutical companies face a new regulatory gap as patients and physicians turn to large language

The era of the ten-blue-link search result is ending. For pharmaceutical marketers, the transition from Google Search to Large Language

Pharmaceutical companies face a new blind spot as patients migrate from search engines to Large Language Models (LLMs) for medical